An investigation of the inclusion of women in clinical trials using a public clinical trials registry

Project Details


Previous research has shown that not enough women are included in clinical trials of new medications. This is a cause for concern for several reasons. Because women's bodies break down medications differently than men, the same drugs that are found to be safe and effective in men may not always be safe and effective for women. Also, women often live longer than men, and are more likely to suffer from other diseases and medical conditions; this means that women use more medications than men, so it is especially important that drugs are safe and effective for women. Some research shows that there are still not enough women included in medical studies relating to treatments for arthritis, heart conditions, and certain types of cancers. However, we do not have information on the overall status of women in clinical trials and what types of trials currently do not include enough women. This study will examine a public database called than includes information about over 100,000 drug studies from nearly 200 countries. I will use the information from this website to study how many women are included in clinical trials, and what types of studies tend to not have enough female participants. This is a very important study because both the government and industry spend a lot of money testing new medications and therapies, with the hope that everyone will benefit from the results that are generated. Getting more information on this topic will help to determine if and why there are not enough women involved in the testing of new medications and pave the way for future policies that can encourage the inclusion of women in the testing of new drugs.

Effective start/end date1/09/1231/08/13


  • Institute of Health Services and Policy Research: $17,509.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.